Epigral Ltd (EPIGRAL) Q2FY27 Concall Summary - Sep-2026 Qtr
Key Takeaways
- Management expects chlorine prices to remain positive, marking a new normal where it is no longer a negative-value co-product due to strong domestic downstream demand.
- The FY31 revenue target of 5,000 crore will be achieved with current and announced capex, with no further major capital-raising rounds anticipated before then.
- The company will increase its renewable energy share to 30-35% within three years through an asset-light SPV model to mitigate volatile coal prices.
Performance Overview
- Delivered 28% year-over-year revenue growth in a challenging operating environment, driven by higher volumes and improved product realizations.
- EBITDA margins were compressed to 18% due to a lag in passing through volatile feedstock prices and increased raw material costs from geopolitical instability.
- The Derivatives & Specialty business was a key growth driver, contributing 57% of total revenue for the quarter.
- Maintained capital expenditure plans with CPVC and Epichlorohydrin (ECH) capacity expansions entering final trial run stages.
- Progressed on new projects, with pilot plants for epoxy resin and the multipurpose plant now ready for customer approvals.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.
Tone & Disclosure
Log in to Stocksigma to read the Tone & Disclosure section of this summary.